Cargando…

CD90(low) glioma-associated mesenchymal stromal/stem cells promote temozolomide resistance by activating FOXS1-mediated epithelial-mesenchymal transition in glioma cells

BACKGROUND: The tumour microenvironment contributes to chemotherapy resistance in gliomas, and glioma-associated mesenchymal stromal/stem cells (gaMSCs) are important stromal cell components that play multiple roles in tumour progression. However, whether gaMSCs affect chemotherapy resistance to the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xue, Bing-zhou, Xiang, Wei, Zhang, Qing, Wang, Hao-fei, Zhou, Yu-jie, Tian, Han, Abdelmaksou, Ahmed, Xue, Jian, Sun, Min-xuan, Yi, Dong-ye, Xiong, Nan-xiang, Jiang, Xiao-bing, Zhao, Hong-yang, Fu, Peng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8278613/ https://www.ncbi.nlm.nih.gov/pubmed/34256854 http://dx.doi.org/10.1186/s13287-021-02458-8

Ejemplares similares

Correction to: CD90(low) glioma-associated mesenchymal stromal/stem cells promote temozolomide resistance by activating FOXS1-mediated epithelial-mesenchymal transition in glioma cells
por: Xue, Bing-zhou, et al.
Publicado: (2021)

CD90 determined two subpopulations of glioma-associated mesenchymal stem cells with different roles in tumour progression
por: Zhang, Qing, et al.
Publicado: (2018)

Current status and potential challenges of mesenchymal stem cell-based therapy for malignant gliomas
por: Zhang, Qing, et al.
Publicado: (2018)

Growth factors contribute to the mediation of angiogenic capacity of glioma-associated mesenchymal stem cells
por: Zhang, Qing, et al.
Publicado: (2021)

Mesenchymal Stromal-Like Cells in the Glioma Microenvironment: What Are These Cells?
por: Clavreul, Anne, et al.
Publicado: (2020)

Genomics and Prognosis Analysis of Epithelial-Mesenchymal Transition in Glioma
por: Tao, Chuming, et al.
Publicado: (2020)

Galangin inhibits epithelial-mesenchymal transition and angiogenesis by downregulating CD44 in glioma
por: Chen, Daliang, et al.
Publicado: (2019)

Triptolide reverses epithelial-mesenchymal transition in glioma cells via inducing autophagy
por: Lai, Minfang, et al.
Publicado: (2021)

Human menstrual blood-derived mesenchymal stem cells as a cellular vehicle for malignant glioma gene therapy
por: Wang, Xiao-Jun, et al.
Publicado: (2017)

Identification of collagen genes related to immune infiltration and epithelial-mesenchymal transition in glioma
por: Yin, Wen, et al.
Publicado: (2021)

Identification of two distinct mesenchymal stromal cell populations in human malignant glioma
por: Svensson, Andreas, et al.
Publicado: (2016)

Temozolomide in malignant glioma
por: Dresemann, Gregor
Publicado: (2010)

TMEM2 induces epithelial-mesenchymal transition and promotes resistance to temozolomide in GBM cells
por: Gao, Lun, et al.
Publicado: (2023)

The silencing of LncRNA-H19 decreases chemoresistance of human glioma cells to temozolomide by suppressing epithelial-mesenchymal transition via the Wnt/β-Catenin pathway
por: Jia, Linwei, et al.
Publicado: (2018)

Epithelial-mesenchymal transition is the main way in which glioma-associated microglia/macrophages promote glioma progression
por: He, Xin, et al.
Publicado: (2023)

IKBKE regulates cell proliferation and epithelial–mesenchymal transition of human malignant glioma via the Hippo pathway
por: Lu, Jie, et al.
Publicado: (2017)

AS602801 sensitizes glioma cells to temozolomide and vincristine by blocking gap junction communication between glioma cells and astrocytes
por: Zhang, Shuai, et al.
Publicado: (2021)

Calumenin contributes to epithelial-mesenchymal transition and predicts poor survival in glioma
por: Yang, Ying, et al.
Publicado: (2021)

The Silencing of LncRNA-H19 Decreases Chemoresistance of Human Glioma Cells to Temozolomide by Suppressing Epithelial-Mesenchymal Transition via the Wnt/β-Catenin Pathway [Retraction]
Publicado: (2022)

Targeting the Epithelial-to-Mesenchymal Transition in Cancer Stem Cells for a Better Clinical Outcome of Glioma
por: Lu, Yu-bao, et al.
Publicado: (2020)

Promising Prognosis Marker Candidates on the Status of Epithelial–Mesenchymal Transition and Glioma Stem Cells in Glioblastoma
por: Takashima, Yasuo, et al.
Publicado: (2019)

Exosomal connexin 43 regulates the resistance of glioma cells to temozolomide
por: Yang, Zhang-Jian, et al.
Publicado: (2021)

Development and validation of a glioma-associated mesenchymal stem cell-related gene prognostic index for predicting prognosis and guiding individualized therapy in glioma
por: Peng, Zesheng, et al.
Publicado: (2023)

Stromal-Modulated Epithelial-to-Mesenchymal Transition in Cancer Cells
por: Atiya, Huda I., et al.
Publicado: (2023)

Roles of long non-coding RNAs in the hallmarks of glioma
por: Xue, Bing-Zhou, et al.
Publicado: (2020)

Combination Therapy for Gliomas Using Temozolomide and Interferon-Beta Secreting Human Bone Marrow Derived Mesenchymal Stem Cells
por: Park, Jae-Hyun, et al.
Publicado: (2015)

NKCC1 involvement in the epithelial-to-mesenchymal transition is a prognostic biomarker in gliomas
por: Sun, Huaiyu, et al.
Publicado: (2020)

Mesenchymal Stromal Cells-Derived β2-Microglobulin Promotes Epithelial–Mesenchymal Transition of Esophageal Squamous Cell Carcinoma Cells
por: Wang, Junjie, et al.
Publicado: (2018)

Enhanced MGMT expression contributes to temozolomide resistance in glioma stem-like cells
por: Qiu, Zhi-Kun, et al.
Publicado: (2014)

FOXC1 silencing inhibits the epithelial-to-mesenchymal transition of glioma cells: Involvement of β-catenin signaling
por: Cao, Qinchen, et al.
Publicado: (2019)

WNK3 promotes the invasiveness of glioma cell lines under hypoxia by inducing the epithelial-to-mesenchymal transition
por: Wang, Yue, et al.
Publicado: (2021)

Knockdown of Long Noncoding RNA CCAT2 Inhibits Cellular Proliferation, Invasion, and Epithelial–Mesenchymal Transition in Glioma Cells
por: Zeng, Jing, et al.
Publicado: (2017)

Differential Characterization of Temozolomide-Resistant Human Glioma Cells
por: Lai, Sheng-Wei, et al.
Publicado: (2018)

Identification and verification of the temozolomide resistance feature gene DACH1 in gliomas
por: Gu, Qiang, et al.
Publicado: (2023)

Inhibition of DNA Repair in Combination with Temozolomide or Dianhydrogalactiol Overcomes Temozolomide-Resistant Glioma Cells
por: Ohba, Shigeo, et al.
Publicado: (2021)

Metformin and temozolomide act synergistically to inhibit growth of glioma cells and glioma stem cells in vitro and in vivo
por: Yu, Zhiyun, et al.
Publicado: (2015)

FoxM1 promotes epithelial-mesenchymal transition of hepatocellular carcinoma by targeting Snai1
por: Yu, Chun-Peng, et al.
Publicado: (2017)

Application of mesenchymal stem cells as a vehicle to deliver replication-competent adenovirus for treating malignant glioma
por: Hai, Cui, et al.
Publicado: (2012)

BAF53a is a potential prognostic biomarker and promotes invasion and epithelial-mesenchymal transition of glioma cells
por: Meng, Li, et al.
Publicado: (2017)

Mesenchymal stem cells deliver synthetic microRNA mimics to glioma cells and glioma stem cells and inhibit their cell migration and self-renewal
por: Lee, Hae Kyung, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_a9fmvj6cpgr195soikfhijmkfl